Southeastern Endocrine and Diabetes
- Company typePrivate
- Founded-
- HeadquartersRoswell, United States
- Headcount1–10
- GTM typeB2C
- OfferingServices
What Southeastern Endocrine and Diabetes does
Southeastern Endocrine & Diabetes, P.C. (SEED) is a privately held professional corporation operating a single endocrinology and internal medicine practice from its headquarters at 1475 Holcomb Bridge Road, Suite 129, in Roswell, Georgia. The practice is led by Dr. John Chip H. Reed, III, who is board-certified in Internal Medicine and Endocrinology & Metabolism by the American Board of Internal Medicine, and serves patients with diabetes and other endocrine disorders. Its service offering combines direct patient consultations, a structured weekend Diabetes School patient-education program staffed by a multidisciplinary team (including a dietician, diabetes educator, nurse practitioner, endocrinologist, podiatrist, and pharmacist), and clinical trial enrollment through its wholly-owned subsidiary Endocrine Research Solutions, Inc., which conducts FDA-approved studies under independent IRB oversight.
The underlying technology stack is conventional community-practice IT: an eClinicalWorks patient portal for records, scheduling, and messaging; downloadable PDF patient forms; an online bill-pay partner; and integrations with five pump and continuous glucose monitor data-sharing platforms (Medtronic CareLink, Tandem t:connect, Glooko for Omnipod, LibreView, and Dexcom Clarity). The practice does not develop proprietary software; it consumes third-party device and EHR products.
Revenue is generated through standard fee-for-service medical billing to insurers and patients, supplemented by pharmaceutical-sponsored clinical trial per-patient payments via Endocrine Research Solutions, where participants receive medication and medical expenses at no cost. Go-to-market is overwhelmingly local and referral-driven, supported by the practice website (seedreed.com), the Diabetes School as a patient-acquisition funnel, and a Facebook page maintained by the research subsidiary. The practice is HIPAA-compliant as a regulatory baseline; it holds no disclosed patents, no external funding, no parent company, and operates only one physical site serving the southeastern United States.
Southeastern Endocrine and Diabetes firmographics
Firmographics- Name
- Southeastern Endocrine and Diabetes
- Legal name
- Southeastern Endocrine & Diabetes, P.C.
- Website
- https://seedreed.com
- Company type
- Private
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Ownership category
- akta.pro rank
Southeastern Endocrine and Diabetes industry classification
Industry- Product category
- Endocrinology and Diabetes Care
- NAICS
- Offices of Physicians (6211)
- SIC
- Services-Offices & Clinics Of Doctors Of Medicine (8011)
- akta.pro primary industry
- Diabetes (General) (HLAKADAA)
Keywords
Where Southeastern Endocrine and Diabetes is headquartered
LocationHeadquarters
- HQ city
- Roswell
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Southeastern Endocrine and Diabetes business model
Business model- GTM type
- B2C
- Offering type
- Services
- Cost components
- Personnel, Operations, Technology or R&D, Others
Distribution channels2 records
Marketing channels3 records
Southeastern Endocrine and Diabetes product offering
Product offeringCore offering
Southeastern Endocrine and Diabetes, P.C. is a physician-led medical practice that diagnoses and treats diabetes and other endocrine disorders at a single office in Roswell, Georgia. The practice augments direct patient care with a weekend Diabetes School education program staffed by a multidisciplinary team and with FDA-approved clinical trials run through its wholly owned subsidiary, Endocrine Research Solutions, Inc.
Product overview
Southeastern Endocrine and Diabetes, P.C. is a medical practice providing specialized endocrinology and diabetes care. The practice operates a single unified service offering centered on direct patient medical care, augmented by the Diabetes School patient education program, the Endocrine Research Solutions clinical trials division, a downloadable patient forms library, and online services including bill pay and an eClinicalWorks patient portal. These components are not separate software products or technology platforms — the practice does not offer a product-as-a-service architecture with modules or tiers.
Differentiator
Problem solved
Functional benefit
Products and services
- Endocrinology and Diabetes Medical Practice Physician-led specialist medical care for diabetes and other endocrine disorders, including diagnosis, treatment, insulin management, and ongoing patient follow-up at the Roswell, Georgia office.
- Diabetes School A weekend patient education program for diabetes patients and their families, covering carbohydrate counting, insulin adjustment, oral agents, exercise, foot care, pumps, meters, complications, and research; classes are taught by a multidisciplinary team including a dietician, diabetes educator, nurse practitioner, endocrinologist, podiatrist, and pharmacist.
- Endocrine Research Solutions, Inc. (Clinical Trials) Wholly owned clinical research division that conducts FDA-approved pharmaceutical clinical trials for new endocrinology and diabetes medications at the practice office; eligible participants receive trial-related medical care and study medication at no cost.
Companies that use Southeastern Endocrine and Diabetes
Customer profileSegments1 record
Ideal customer profiles1 record
Southeastern Endocrine and Diabetes technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature1 record
Southeastern Endocrine and Diabetes partnerships and signals
Strategic signalPartnerships
One partnership is on record.
- Endocrine Research Solutions, Inc.coreClinical research department established by the practice to conduct clinical trials at the office. The research is FDA approved and follows strict criteria, reviewed by SEED physicians and an independent Institutional Review Board (IRB). All medical expenses for trial participants including medication are provided at no cost.
Recent moves5 records
Expansion highlights4 records
Southeastern Endocrine and Diabetes competitors and assessment
Company assessmentEmerging players
- Virta Health: Telehealth-first diabetes reversal and management platform that delivers endocrinology and diabetes care remotely. Comparable in clinical focus on type 2 diabetes management but uses a virtual care model competing for the same patient demand.
- Cecelia Health (formerly Fit4D): Virtual diabetes and chronic condition management company providing telehealth endocrinology and coaching services. Overlaps with SEED's diabetes education mission but delivers it via a scalable, technology-enabled model.
Broad incumbents
- Northside Hospital Endocrinology: Endocrinology services line of a large Atlanta-area health system offering diabetes and endocrine care within an integrated delivery network. Competes for the same patient pool but with much broader scale and employed-physician model.
- Emory Endocrinology: Academic endocrinology division of Emory Healthcare in the Atlanta metro, offering specialty diabetes and endocrine services within a major academic medical center. Competes for complex endocrinology referrals at significantly larger scale.
- Wellstar Endocrinology: Endocrinology specialty services operated by Wellstar Health System, a major regional health system serving the greater Atlanta area. Overlapping patient population but delivered through a multi-hospital system rather than an independent practice.
Others
- Tandem Diabetes Care: Insulin pump manufacturer whose t:connect platform is integrated into SEED's device data sharing stack. A device ecosystem partner that influences which patients seek care at tech-forward endocrinology practices.
- Dexcom: Leading continuous glucose monitoring (CGM) manufacturer whose Clarity platform is integrated into SEED's data sharing ecosystem. Not a competitor, but a key device partner and supplier shaping the practice's clinical workflow.
- Medtronic Diabetes: Major insulin pump and CGM manufacturer whose CareLink Personal platform is integrated by SEED. An enabler/ecosystem partner rather than a competitor, but its commercial decisions directly affect SEED's pump-using patients.
Direct peers
- Atlanta Diabetes Associates: An independent endocrinology and diabetes specialty practice serving the Atlanta metro area. Highly comparable to SEED in patient focus, specialty mix, and private-practice model in the same regional market.
- Atlanta Endocrine Associates: Specialist endocrinology group practice in the Atlanta metro providing diabetes and endocrine disorder care. Directly comparable in clinical scope and independent private-practice delivery model.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks5 records
Key highlights6 records
Customer concentration
Southeastern Endocrine and Diabetes social profiles
Digital presenceSoutheastern Endocrine and Diabetes compliance and trust
Trust signalCompliance1 record
Southeastern Endocrine and Diabetes financial estimates
Financial estimateRevenue estimate
Valuation estimate
Southeastern Endocrine and Diabetes leadership team
Management profileNumber of profiles
Profiles1 record
Southeastern Endocrine and Diabetes subsidiaries and ownership
Company hierarchySubsidiaries1 record
Southeastern Endocrine and Diabetes funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Southeastern Endocrine and Diabetes M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Southeastern Endocrine and Diabetes
What does Southeastern Endocrine and Diabetes do?
Southeastern Endocrine and Diabetes, P.C. is a physician-led medical practice that diagnoses and treats diabetes and other endocrine disorders at a single office in Roswell, Georgia. The practice augments direct patient care with a weekend Diabetes School education program staffed by a multidisciplinary team and with FDA-approved clinical trials run through its wholly owned subsidiary, Endocrine Research Solutions, Inc.
Is Southeastern Endocrine and Diabetes a public or private company?
Southeastern Endocrine and Diabetes is a private company. It is classified as founder individual operated bootstrapped and is currently operating.
When was Southeastern Endocrine and Diabetes founded?
Southeastern Endocrine and Diabetes was founded in -1. It employs 1 to 10 people.
Where is Southeastern Endocrine and Diabetes based?
Southeastern Endocrine and Diabetes is headquartered in Roswell, United States, in the North America region.
Who are Southeastern Endocrine and Diabetes's main competitors?
Emerging players on record are Virta Health and Cecelia Health (formerly Fit4D). Broad incumbents are Northside Hospital Endocrinology, Emory Endocrinology and Wellstar Endocrinology. Others are Tandem Diabetes Care, Dexcom and Medtronic Diabetes. Direct peers are Atlanta Diabetes Associates and Atlanta Endocrine Associates.
Does Southeastern Endocrine and Diabetes have an API?
No public API is recorded for Southeastern Endocrine and Diabetes.
What industry is Southeastern Endocrine and Diabetes in?
Southeastern Endocrine and Diabetes's product category is Endocrinology and Diabetes Care. Its primary akta.pro industry code is HLAKADAA, Diabetes (General). Its NAICS code is 6211 and its SIC code is 8011.